[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644346":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":49,"collaborators":18,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":18,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":73,"overallStatus":77,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Bupivacaine group","ACTIVE_COMPARATOR","10 ml of bupivacaine solution will be administered. Dose: 10 ml bupivacaine concentration 0.5% (each 1 ml contains 5 mg; total volume 10 ml equivalent to total 50 mg) will be given.",[13],"Drug: Bupivacaine",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","No intervention will be administered",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DRUG","Bupivacaine","Superficial parasternal block will be given to assess diameter of IMA by using US to assess caliber and ease of harvesting.",[9],[26],{"name":27,"affiliation":28,"role":29},"Sarah H Elghareeb, MD","Ain Shams","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Sarah hamdy Elghareeb, MD","CONTACT","+201012434690","sarahhamdy@med.asu.edu.eg",[37],{"facility":38,"status":18,"city":39,"state":40,"zip":18,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":18},"Faculty of Medicine ,Ain Shams University","Cairo","Cairo Governorate","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],31.24967,30.06263,{"lat":47,"lon":46},{"type":29,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"sarah hamdy","Lectuer of Anaethesia and intensive care","100644346","phase-3-influence-of-superficial-parasternal-intercostal-plane-block-on-internal-thoracic-artery-caliber-to-facilitate-surgical-harvesting-in-cabg-100644346",false,"NCT07663435","Influence of Superficial Parasternal Intercostal Plane Block on Internal Thoracic Artery Caliber to Facilitate Surgical Harvesting in CABG","IMA CABG PIPB","Inclusion Criteria:\n\n* • Age group: Adult patients from age of 22 to 65 years.\n\n  * Sex: Both sexes\n  * Patients undergoing CABG with IMA harvesting\n\nExclusion Criteria:\n\n* • Patients with pre-existing active bloodstream infection or systemic infection\n\n  * Refuse consent\n  * IMA graft not suitable\n  * Morbidly obese (BMI \\> 40 )\n  * Hemodynamic instability\n  * Severe pulmonary disease\n  * Previous thoracic surgeries (makes it difficult to harvest IMA)\n  * Advanced malignancy or chronic disease with life expectancy less than six months\n  * Emergency surgery","ALL","22 Years","65 Years",{"count":63,"type":64},50,"ESTIMATED","INTERVENTIONAL",[67],"PHASE3","Influence of Superficial Parasternal Intercostal Plane Block (SPIPB) on Internal Thoracic Artery (ITA) Caliber and Surgical Harvesting Efficiency in Coronary Artery Bypass Grafting (CABG)",[70,71,72],"Pain Management","Parasternal Block","CABG Graft Integrity",[74,75,76],"IMA","CABG","SPIPB","NOT_YET_RECRUITING","2026-06-17",{"date":80,"type":81},"2026-06-23","ACTUAL",{"date":83,"type":64},"2026-07",{"date":85,"type":64},"2026-12-31",{"name":5,"class":6},1]